1.
Kang Zhang, Xin Yang, Yifei Wang, et al. Artificial intelligence in drug development. Nature Medicine. 2025;31(1):45-59. doi:10.1038/s41591-024-03434-4
Humans
1.
Maria T. Baltazar, Sophie Cable, Richard Cubberley, et al. Making safety decisions for a sunscreen active ingredient using next-generation risk assessment: Benzophenone-4 case study. ALTEX. 2025;42(3):511-530. doi:10.14573/altex.2501201
1.
Jacintha Shenton, Imein Bousnina, Michael Oropallo, et al. Opportunities and insights from pharmaceutical companies on the current use of new approach methodologies in nonclinical safety assessment. Drug Discovery Today. 2025;30(4):104328. doi:10.1016/j.drudis.2025.104328
1.
Suel-Kee Kim, Seungmae Seo, Genevieve Stein-O’Brien, et al. Individual variation in the emergence of anterior-to-posterior neural fates from human pluripotent stem cells. Stem Cell Reports. 2024;19(9):1336-1350. doi:10.1016/j.stemcr.2024.07.004
1.
Li Pang, Chengzhong Cai, Praful Aggarwal, et al. Predicting oncology drug-induced cardiotoxicity with donor-specific iPSC-CMs-a proof-of-concept study with doxorubicin. Toxicological Sciences: An Official Journal of the Society of Toxicology. 2024;200(1):79-94. doi:10.1093/toxsci/kfae041
1.
Feline W. Lindhout, Fenna M. Krienen, Katherine S. Pollard, Madeline A. Lancaster. A molecular and cellular perspective on human brain evolution and tempo. Nature. 2024;630(8017):596-608. doi:10.1038/s41586-024-07521-x
1.
Noelia Antón-Bolaños, Irene Faravelli, Tyler Faits, et al. Brain Chimeroids reveal individual susceptibility to neurotoxic triggers. Nature. 2024;631(8019):142-149. doi:10.1038/s41586-024-07578-8
1.
David Pamies, Jason Ekert, Marie-Gabrielle Zurich, et al. Recommendations on fit-for-purpose criteria to establish quality management for microphysiological systems and for monitoring their reproducibility. Stem Cell Reports. 2024;19(5):604-617. doi:10.1016/j.stemcr.2024.03.009
1.
Li Pang, Chengzhong Cai, Praful Aggarwal, et al. Predicting oncology drug-induced cardiotoxicity with donor-specific iPSC-CMs-a proof-of-concept study with doxorubicin. Toxicological Sciences: An Official Journal of the Society of Toxicology. 2024;200(1):79-94. doi:10.1093/toxsci/kfae041
1.
Suel-Kee Kim, Seungmae Seo, Genevieve Stein-O’Brien, et al. Individual variation in the emergence of anterior-to-posterior neural fates from human pluripotent stem cells. Stem Cell Reports. 2024;19(9):1336-1350. doi:10.1016/j.stemcr.2024.07.004